Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05131451 · ClinicalTrials.gov registry record · NA
ACCESS: AI for pediatriC diabetiC Eye examS Study
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT05131451: Completed NA study, sponsored by Johns Hopkins University.
NCT05131451 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05131451, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if providing in clinic point-of-care autonomous AI diabetic retinopathy exams improves screening rates compared to standard of care referral to an eye care provider, in a randomized control trial in a racially and ethnically diverse cohort of youth.
Interventions
- DIAGNOSTIC_TEST Point of Care Autonomous AI diabetic retinopathy exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2021-11-24 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05131451
The ClinicalTrials.gov registry entry for NCT05131451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Point of Care Autonomous AI diabetic retinopathy exam is the first listed.
NCT05131451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05131451 about?
NCT05131451 is a clinical study titled "ACCESS: AI for pediatriC diabetiC Eye examS Study". The purpose of this study is to determine if providing in clinic point-of-care autonomous AI diabetic retinopathy exams improves screening rates compared to standard of care referral to an eye care provider, in a randomized control trial in a racially and ethnically diverse cohort of youth.
What is the current status of trial NCT05131451?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2021-11-24. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05131451?
The interventions under investigation include: Point of Care Autonomous AI diabetic retinopathy exam (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05131451?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.